DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,121,000 | -33.2% | 204,430 | +23.7% | 0.01% | -41.2% |
| Q2 2021 | $6,168,000 | +64.6% | 165,251 | +12.7% | 0.02% | +30.8% |
| Q1 2021 | $3,748,000 | +112.2% | 146,587 | +82.9% | 0.01% | +85.7% |
| Q4 2020 | $1,766,000 | +69.8% | 80,155 | +38.7% | 0.01% | +40.0% |
| Q3 2020 | $1,040,000 | +3.1% | 57,804 | +45.5% | 0.01% | -16.7% |
| Q2 2020 | $1,009,000 | +151.6% | 39,715 | +82.1% | 0.01% | +100.0% |
| Q1 2020 | $401,000 | -6.3% | 21,805 | +12.2% | 0.00% | 0.0% |
| Q4 2019 | $428,000 | +83.7% | 19,442 | +20.1% | 0.00% | +50.0% |
| Q3 2019 | $233,000 | – | 16,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |